A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise

Completed · Phase 4

Conditions studied: Bronchospasm, Activity/Exercise Induced Bronchospasm

In brief

During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.

Key facts

Study ID

NCT00118716

Run by

GlaxoSmithKline

People needed

248

Starts

2003-12-23

Expected to finish

2006-04-23

Last updated by the study team

2019-02-05

Who can join

Age: 4 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with persistent asthma for 3 months or longer.
• Experienced worsened asthma symptoms during physical activity.
• Using an inhaled steroid for the previous 4 weeks or longer (such as Aerobid, Azmacort, Flovent, Pulmicort, QVAR, and Vanceril).

You may not qualify if…

• Used systemic steroids as either liquids, pills, or injections to treat asthma within the previous 3 months.
• Have only intermittent, seasonal, or exercise-induced asthma, and not persistent asthma.
• Admitted to a hospital within the previous 6 months due to asthma symptoms.
• Any poorly controlled medical conditions that may make study participation unsafe or inappropriate in the opinion of the study physician (such as cystic fibrosis, congenital heart disease, insulin dependent diabetes, glaucoma, drug allergies, etc.)
• The study physician will evaluate other medical criteria.

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Palmdale, California, United States
• GSK Investigational Site — Paramount, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Centennial, Colorado, United States
• GSK Investigational Site — Englewood, Colorado, United States
• GSK Investigational Site — Lakewood, Colorado, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Tallahassee, Florida, United States
• GSK Investigational Site — Lilburn, Georgia, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Hoffman Estates, Illinois, United States
• GSK Investigational Site — Metairie, Louisiana, United States
• GSK Investigational Site — Metairie, Louisiana, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — Glen Burnie, Maryland, United States
• GSK Investigational Site — North Dartmouth, Massachusetts, United States
• GSK Investigational Site — Minneapolis, Minnesota, United States
• GSK Investigational Site — Papillion, Nebraska, United States
• GSK Investigational Site — Skillman, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.